Craig A. Belon, Ph.D.
Affiliations: | 2010 | Biochemistry and Molecular Biology | New York Medical College, New York, NY, United States |
Area:
Biochemistry, Molecular Biology, Virology BiologyGoogle:
"Craig Belon"Parents
Sign in to add mentor| David N. Frick | grad student | 2010 | New York Medical College | |
| (Novel Inhibitors of the Hepatitis C virus NS3 Helicase and Mechanism of Action.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li K, Frankowski KJ, Belon CA, et al. (2012) Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline. Journal of Medicinal Chemistry. 55: 3319-30 |
| Peng LF, Schaefer EA, Maloof N, et al. (2011) Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase. The Journal of Infectious Diseases. 204: 609-16 |
| Belon CA, High YD, Lin TI, et al. (2010) Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor. Biochemistry. 49: 1822-32 |
| Belon CA, Frick DN. (2009) Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C. Future Virology. 4: 277-293 |
| Belon CA, Frick DN. (2009) Fuel specificity of the hepatitis C virus NS3 helicase. Journal of Molecular Biology. 388: 851-64 |
| Belon CA, Frick DN. (2008) Monitoring helicase activity with molecular beacons. Biotechniques. 45: 433-40, 442 |